These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18632843)

  • 1. CTGF inhibits BMP-7 signaling in diabetic nephropathy.
    Nguyen TQ; Roestenberg P; van Nieuwenhoven FA; Bovenschen N; Li Z; Xu L; Oliver N; Aten J; Joles JA; Vial C; Brandan E; Lyons KM; Goldschmeding R
    J Am Soc Nephrol; 2008 Nov; 19(11):2098-107. PubMed ID: 18632843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal expression profile and distribution pattern indicate a role of connective tissue growth factor (CTGF/CCN-2) in diabetic nephropathy in mice.
    Roestenberg P; van Nieuwenhoven FA; Joles JA; Trischberger C; Martens PP; Oliver N; Aten J; Höppener JW; Goldschmeding R
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1344-54. PubMed ID: 16380465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.
    Wang S; Denichilo M; Brubaker C; Hirschberg R
    Kidney Int; 2001 Jul; 60(1):96-105. PubMed ID: 11422741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal bone morphogenetic protein-7 protects against diabetic nephropathy.
    Wang S; de Caestecker M; Kopp J; Mitu G; Lapage J; Hirschberg R
    J Am Soc Nephrol; 2006 Sep; 17(9):2504-12. PubMed ID: 16899516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
    Makino H; Mukoyama M; Sugawara A; Mori K; Suganami T; Yahata K; Fujinaga Y; Yokoi H; Tanaka I; Nakao K
    Clin Exp Nephrol; 2003 Mar; 7(1):33-40. PubMed ID: 14586741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy.
    Wahab NA; Yevdokimova N; Weston BS; Roberts T; Li XJ; Brinkman H; Mason RM
    Biochem J; 2001 Oct; 359(Pt 1):77-87. PubMed ID: 11563971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMP signaling and podocyte markers are decreased in human diabetic nephropathy in association with CTGF overexpression.
    Turk T; Leeuwis JW; Gray J; Torti SV; Lyons KM; Nguyen TQ; Goldschmeding R
    J Histochem Cytochem; 2009 Jul; 57(7):623-31. PubMed ID: 19255250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal connective tissue growth factor correlates with glomerular basement membrane thickness and prospective albuminuria in a non-human primate model of diabetes: possible predictive marker for incipient diabetic nephropathy.
    Thomson SE; McLennan SV; Kirwan PD; Heffernan SJ; Hennessy A; Yue DK; Twigg SM
    J Diabetes Complications; 2008; 22(4):284-94. PubMed ID: 18413184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the TGFbeta/Smad signaling pathway in mesangial cells by CTGF/CCN2.
    Wahab NA; Weston BS; Mason RM
    Exp Cell Res; 2005 Jul; 307(2):305-14. PubMed ID: 15950619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis.
    Riser BL; Denichilo M; Cortes P; Baker C; Grondin JM; Yee J; Narins RG
    J Am Soc Nephrol; 2000 Jan; 11(1):25-38. PubMed ID: 10616837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli.
    Wahab NA; Schaefer L; Weston BS; Yiannikouris O; Wright A; Babelova A; Schaefer R; Mason RM
    Diabetologia; 2005 Dec; 48(12):2650-60. PubMed ID: 16270194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Connective tissue growth factor is associated with the early renal hypertrophy in uninephrectomized diabetic rats.
    Liu BC; Huang HQ; Luo DD; Ma KL; Liu DG; Liu H
    Chin Med J (Engl); 2006 Jun; 119(12):1010-6. PubMed ID: 16805985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue growth factor increases matrix metalloproteinase-2 and suppresses tissue inhibitor of matrix metalloproteinase-2 production by cultured renal interstitial fibroblasts.
    Yang M; Huang H; Li J; Huang W; Wang H
    Wound Repair Regen; 2007; 15(6):817-24. PubMed ID: 18028129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.
    McLennan SV; Wang XY; Moreno V; Yue DK; Twigg SM
    Endocrinology; 2004 Dec; 145(12):5646-55. PubMed ID: 15345671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor expressed in tubular epithelium plays a pivotal role in renal fibrogenesis.
    Okada H; Kikuta T; Kobayashi T; Inoue T; Kanno Y; Takigawa M; Sugaya T; Kopp JB; Suzuki H
    J Am Soc Nephrol; 2005 Jan; 16(1):133-43. PubMed ID: 15574513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy.
    Wang SN; Lapage J; Hirschberg R
    J Am Soc Nephrol; 2001 Nov; 12(11):2392-2399. PubMed ID: 11675415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
    Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
    FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Connective tissue growth factor synergistically with transforming growth factor beta 1 to promote renal fibrosis].
    Yang M; Huang HC; Li JZ; Wang HY
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):569-73. PubMed ID: 15144592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connective tissue growth factor-mediated angiotensin II-induced hypertrophy of proximal tubular cells.
    Liu BC; Chen L; Sun J; Huang HQ; Ma KL; Liu H; Liu DG; Zhang XL
    Nephron Exp Nephrol; 2006; 103(1):e16-26. PubMed ID: 16374037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.